| Therapy (30) |  |
| Therapy (30) | |
Light-switchable drugs have been explored in other fields such as cancer therapy, but not for antibiotics. Organic chemist Ben Feringa at Groningen and his co-workers used an existing light-switchable unit called azobenzene,
Montclare explains that in addition to therapeutic formulations which could prevent nerve damage in the event of a gas attack
Plans are under way to begin developing therapeutic applications. Michelle Zhang a coauthor of the paper and, at the time, a high school intern in Bonneau lab, first broached the idea.
COLLATERAL DAMAGE or breast cancer prevention and DCIS therapy effective drug concentrations are required in the breast.
Tamoxifen is an anti-estrogen therapy for a type of breast cancer that requires estrogen to grow.
The work creates the potential to develop lectroceuticaltreatments as alternatives to drug therapies, says William Newsome, professor of neurobiology and director of the Stanford Neurosciences Institute.
when selecting the most effective therapy and appropriate dosage. The investigators are currently designing a study to correlate pharmacokineticshe time course of drug metabolismith genotype.
In the future such a clone could be a source of stem cells for super-personalized therapies made from people's own DNA.
but more information about the microbiome is needed to effectively design such therapies. he paper lead author is Hiroki Ando, an MIT research scientist.
who was involved not in the research. his is a big step in the development of phage therapies with predictable outcomes and a good demonstration of
patientsadherence to long-term therapies for chronic illnesses is only 50 percent in developed countries, with lower rates of adherence in developing nations.
they envision an emerging field of orally delivered devices that can maximize adherence and therapeutic efficacy.
and bacterianfortunately prevents targeted therapies from reaching the lungs. Other attempts to penetrate the barrier with nanoparticles were unsuccessful
they then went on to develop a therapeutic patch made from collagen that incorporated this compound.
Others are developing stem-cell therapies, such as those from Stempeutics, Novadip or Bonus Biogroup. In this method
but more information about the microbiome is needed to effectively design such therapies.""The paper's lead author is Hiroki Ando, an MIT research scientist.
Virginia, by Revivicor, a division of the biotechnology company United Therapeutics. That company founder and co-CEO, Martine Rothblatt, is noted a futurist who four years ago began spending millions to supply researchers with pig organs
July 28, 2015-If you are a regular reader of this blog then you have read about the importance of our research into stem cells and their therapeutic value.
and have the yeast do all the chemical steps required downstream to make your target therapeutic drug."
"The team tested the therapeutic potential of the nanoparticles by loading them with an anti-melanoma drug
so you can do multidrug therapy with the same particles.""""By using defined surface chemistry,
The paper,"Tunable luminescent carbon nanospheres with well-defined nanoscale chemistry for synchronized imaging and therapy,"is available online:
and non-invasively, opening the door to many other known therapies, such as the cases that dexamethasone cannot be applied safely systemically in large concentrations.
2015nanomedicine Nanoparticle'wrapper'delivers chemical that stops fatty buildup in rodent arteries Experimental therapy restores normal fat metabolism in animals with atherosclerosis June 23rd, 2015picosun ALD
2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Nanoparticle'wrapper'delivers chemical that stops fatty buildup in rodent arteries Experimental therapy restores normal fat metabolism
and the Environment June 24th, 2015nanoparticle'wrapper'delivers chemical that stops fatty buildup in rodent arteries Experimental therapy restores normal fat metabolism in animals with atherosclerosis June 23rd,
patients adherence to long-term therapies for chronic illnesses is only 50 percent in developed countries, with lower rates of adherence in developing nations.
they envision an emerging field of orally delivered devices that can maximize adherence and therapeutic efficacy y
so you can do multidrug therapy with the same particles.""H/T: Techrada d
#World first underground urban farm opens for business in London The world first underground urban farm has started trading in London,
or plan for the next one or rule out therapies that are unlikely to remain effective for long said Duke graduate student Pablo Gainza-Cirauqui who co-authored the paper.
Researchers develop a faster way to treat the heart after a heart attack Stem cell have been the main focus of healing therapy research
For healing after a heart attack, the ideal time to administer these therapies is when reopening the clogged blood vessel
A new study in the American Journal of Physiology--Heart and Circulatory Physiology reports a more practical approach called microsphere therapy that can be kept on hand
The therapy, however, did not improve heart function. It also did not decrease the size of the area damaged by the heart attack or the composition of the scar.
the study shows that microsphere therapy can potentially be an"off-the-shelf and immediate alternative to stem cell therapy"for treating heart attacks and potentially other diseases s
which allows for a better therapeutic potential. The team of researchers tested the therapeutic potential of these carbon nanoparticles by loading them with an anti-melanoma drug
and mixing them in a topical solution that was applied to pig skin. However, scientists have to make sure they coated particles properly,
as well as to make it carry several different drugs at the same time to allow for a multidrug therapy with the same particles.
which will eventually lead to innovative drug therapies for cancer and other diseases i
#Actuators that mimic ice plants Engineers developing moveable robot components may soon take advantage of a trick plants use.
patientsadherence to long-term therapies for chronic illnesses is only 50 percent in developed countries, with lower rates of adherence in developing nations.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011